SynthomerFRA:7YC2 -9.65%65 EBITDA Margin % is 0.11% as of Dec. 2025, which is 99% below its 10-year median of 10.18. GuruFocus rates FRA:7YC2 with a GF Score™ of 65/100 and a GF Value™ of €1.26 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,584 Chemicals companies, Synthomer ranks worse than 75.51% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Synthomer's EBITDA for the
six
months ended in Dec. 2025 was €1 Mil. Synthomer's Revenue for the
six
months ended in Dec. 2025 was €931 Mil. Therefore, Synthomer's EBITDA margin for the quarter that ended in Dec. 2025 was 0.11%.
Synthomer (FRA:7YC2) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Synthomer EBITDA Margin % Related Terms
Synthomer EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Synthomer's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7YC2 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Synthomer's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthomer EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Synthomer's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Synthomer's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthomer (FRA:7YC2) has a EBITDA Margin % of 0.11% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Synthomer and its competitors. This is 99% below median its historical median of 10.18. Over the past decade, Synthomer's EBITDA Margin % has ranged from 3.10 to 19.35. According to the industry distribution chart, Synthomer ranks #1196 out of 1584 companies in the Chemicals industry, placing it in the top 75.5%.
Is Synthomer's EBITDA Margin % too high?
Synthomer's current EBITDA Margin % of 0.11% is 99% below median its 10-year median of 10.18. Over the past 10 years, this metric has ranged from a low of 3.10 to a high of 19.35. The Chemicals industry median EBITDA Margin % is 9.64. Synthomer's value of 0.11% is 98.9% below this industry median. Based on the distribution chart, Synthomer ranks #1196 out of 1584 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Synthomer has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Synthomer's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Synthomer ranks #1196 out of 1584 companies for EBITDA Margin %. This places Synthomer in the lower half of its industry. The industry median EBITDA Margin % is 9.64. Synthomer's value of 0.11% is 98.9% below this benchmark. Historically, Synthomer's own EBITDA Margin % has ranged from 3.10 to 19.35 over the past decade. While the company's 10-year median is 10.18 vs. the industry median of 9.64, Synthomer has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synthomer's current EBITDA Margin % of 0.11% is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Synthomer and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthomer's current EBITDA Margin % is 0.11%, which is 99% below median its own 10-year median of 10.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthomer stock overvalued right now?
Based on GuruFocus' analysis, Synthomer (FRA:7YC2) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.26, compared to a current price of €1.03 — trading 18.3% below its estimated fair value. The current EBITDA Margin % is 0.11%, which is 99% below median its 10-year median of 10.18 and 98.9% below the Chemicals industry median of 9.64. Synthomer's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Synthomer (FRA:7YC2), the current EBITDA Margin % is 0.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthomer (FRA:7YC2) Overvalued in 2026?
Based on GuruFocus' analysis, Synthomer stock appears to be undervalued.
The current stock price of €1.03 is trading 18.3% below its estimated GF Value™ of €1.26.
GuruFocus considers Synthomer to be Modestly Undervalued.
Key valuation signals for FRA:7YC2:
EBITDA Margin %: 0.11% (99% below median its 10-year median of 10.18)
GF Value™: €1.26 vs. price of €1.03 (18.3% below fair value)
Industry Position: 98.9% below the Chemicals median (#1196 of 1584)
No single metric tells the full story. See the FRA:7YC2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthomer PLC is a specialty chemicals company. It supplies a variety of chemicals including latex and adhesives, which are used in a wide range of markets such as construction, coatings, textiles, paper, and healthcare. The company's markets and products include Adhesives, Coatings, Construction, Health & Protection, Energy Solutions, Performance Materials and Paper, Carpet & Foam. The segments of the company are Coatings & Construction Solutions, Adhesive Solutions, Health & Protection and Performance Materials, and corporate. A vast majority of the company's revenue is generated from Coatings & Construction Solutions.
65GF Score
Get the complete analysis for FRA:7YC2
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7YC2 has been successfully added to your 
